News
Watch
Conferences
Events
Partners
Publications
Resources
Biomarker Consortium
Subscribe

Refining Therapeutic Strategies for Follicular Lymphoma

Refining Therapeutic Strategies for Follicular Lymphoma

Episodes

Specialty:

All

Year:

All

EP. 1: Follicular Lymphoma: Outcomes After Immunochemotherapy

January 5th 2018

EP. 2: Upfront Therapy Strategies in Follicular Lymphoma

January 5th 2018

EP. 3: Challenging the Role of Maintenance Therapy in FL

January 5th 2018

EP. 4: Predicting and Analyzing Response in Follicular Lymphoma

January 5th 2018

EP. 5: Choosing Second-Line Therapy for Relapsed/Refractory FL

January 5th 2018

EP. 6: Third-Line Treatment for FL: PI3 Kinase Inhibitors

January 5th 2018

EP. 7: Follicular Lymphoma: Optimizing Novel Agent Therapy

January 5th 2018

EP. 8: Follicular Lymphoma: Novel Approaches With Rituximab

January 5th 2018

EP. 9: Novel Agents in FL: Unmet Needs and Potential Uses

January 5th 2018

EP. 10: FL: Potential for SYK/JAK Inhibitors or Azacitidine

January 5th 2018

EP. 11: Immunotherapy in the Treatment of Follicular Lymphoma

January 5th 2018

EP. 12: The Future Treatment of Follicular Lymphoma

January 5th 2018

Trending on OncLive

FDA Approves Zidesamtinib in Pretreated ROS1+ NSCLC

FDA Accepts NDA for Daraxonrasib in Previously Treated Metastatic Pancreatic Cancer

Dr Patel on the Unmet Need in EGFR+ Transformed Small Cell Lung Cancer

Dr Galsky on Systemic Therapy Advances in Muscle-Invasive Bladder Cancer

Dr Cooper on Biomarker Selection for DLL3-Targeted Therapies in ES-SCLC